Webinar Date: Tuesday, July 16, 2024

Webinar Time: 11 AM ET / 8 AM PT

Automated manufacturing systems provide valuable advantages for cell therapy production, including decreased reliance on manual labor, enhanced uniformity, and decreased expenses. Yet, the shift from manual to automated procedures requires incorporating live process data in both development and cGMP manufacturing processes.

The levels of glucose and lactate in cells can indicate their health and growth rates. By analyzing these alongside the rate of perfusion, it is possible to improve the efficiency of media usage and identify the best time for harvesting. The collaboration between automated cell expansion systems such as Quantum Flex and MAVEN improves our understanding of processes and allows for real-time adjustments to conditions.

During this webinar, we will explore the impact of efficient monitor and control of glucose and lactate levels in the cell culture environment and how it can influence T cell differentiation and potentially improve the efficacy of cell therapies by producing more suitable cell products.

Key Takeaways:
  • Learn about increasing robustness and decreasing cost of goods for cell therapy manufacturing
  • Explore enabling the creation and maintenance of optimal cell expansion conditions
  • Learn about the advantages of real-time monitoring of key process parameters for improving cell therapy process development